🌱 KidneyEnergy.com

← brief for 2026-10-05 · Slowing decline

Trajectories of Albuminuria and Non-Albumin Proteinuria After Sequential Addition of Finerenone for Residual Albuminuria Despite Established SGLT2 Inhibitor Therapy in Diabetic Kidney Disease: A Real-World Cohort Study.

Article C Peer reviewed Observational

Key takeaways

This study followed 86 people with diabetic kidney disease. It looked at protein in the urine after adding a new drug. This is an observational study, so it shows a link, not proof of cause.

Who did this work

Choi MS · Yu M · Kim HW · Lee M · Lee YH · Kang ES · Cha BS · Lee BW

Source

Article · PubMed, the drug frontier · 2026 Oct 5
https://pubmed.ncbi.nlm.nih.gov/42833666/